Skip to main content
Top

Current Treatment Options in Oncology

Issue 10/2015

Content (5 Articles)

Lung Cancer (HA Wakelee, Section Editor)

Locally Advanced Non-Small Cell Lung Cancer: Optimal Chemotherapeutic Agents and Duration

Hirva Mamdani, Shadia I. Jalal, Nasser Hanna

Lung Cancer (HA Wakelee, Section Editor)

Generations of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Perils and Progress

Emily H. Castellanos, Leora Horn

Lung Cancer (HA Wakelee, Section Editor)

New Treatment Options for ALK-Rearranged Non-Small Cell Lung Cancer

Laird Cameron, Benjamin Solomon

Lung Cancer (HA Wakelee, Section Editor)

Management of Dermatologic Complications of Lung Cancer Therapies

Silvina B. Pugliese, Joel W. Neal, Bernice Y. Kwong

Open Access Upper Gastrointestinal Cancers (L Rajdev, Section Editor)

Targeted Therapy in Biliary Tract Cancers

Amartej Merla, Kenneth G. Liu, Lakshmi Rajdev

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine